SEC Form 4 · accession 0001209191-18-014179
Clearside Biomedical, Inc. · CLSD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brion S. Raymond
Officer — Chief Commercial Officer
Period of report
Feb 26, 2018
Accepted (ET)
Feb 27, 2018 · 6:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001539029
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $6.23 | Feb 26, 2018 | A | 80,000 | A | — | Feb 25, 2028 | Common Stock | 80,000 | 80,000 | D |
Explanation of responses
- F1One-fourth of the shares underlying this option vest on February 26, 2019 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.